Trial Profile
Association of genetic polymorphism with clinical efficacy of imatinib in patients with gastrointestinal stromal tumours
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 01 Sep 2015
Price :
$35
*
At a glance
- Drugs Imatinib (Primary)
- Indications Gastrointestinal stromal tumours
- Focus Pharmacogenomic; Pharmacokinetics; Therapeutic Use
- 01 Sep 2015 New trial record